$BRM.V $BIRMF Over 100% growth with margin improvement and a growing backlog. 2x annualized earnings. Main problem is they have to restructure or pay off some debt including a couple convertible notes. http://finance.yahoo.com/news/biorem-reports-increased-revenues-earnings-200000979.html